BRCA1 and breast cancer: In approximately 15% of the DNA mutation scannings of BRCA1 or BRCA2 in breast cancer families, the test result is difficult to interpret because an unclassified variant is found (UV, or 'variant of uncertain clinical significance' (VUCS) or 'variant of uncertain significance' (VUS) [1].